Log In
Print this Print this

melflufen (formerly J1)

  Manage Alerts
Collapse Summary General Information
Company Oncopeptides AB
DescriptionProdrug of melphalan
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationMultiple myeloma (MM)
Indication DetailsTreat relapsed and/or relapsed-refractory multiple myeloma (MM)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today